Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BioMarin Submits Kuvan For Phenylketonuria

May 24 2007

• By Pamela Taulbee

Related Content

BioMarin Begins Phase II Study Of 6R-BH4 For Sickle Cell Disease

May 02 2007

BioMarin Anticipates FDA Approval Of Phenoptin In Late 2007

Jan 19 2007

BioMarin Hypertension Candidate Fails Phase II Endpoint

Feb 20 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window